A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment.  TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients.  TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers

Biotechnology

Clinical Trials

Health Care

TORL BioTherapeutics, LLC

Mark Alles

Gajanan Bhat

Christine Palma Loggins

Steve Ritland

Lee Sailor

Frank Becking

Aran Maree M.d.

Dave Licata

The Leadership Team at TORL BioTherapeutics, LLC is responsible for setting the strategic direction and overseeing the company's operations to advance the development of novel antibody-based therapeutics for cancer treatment. This team ensures effective management and execution of clinical trials, regulatory compliance, and the translation of research into viable clinical applications, while fostering organizational growth and securing necessary funding.

Leadership Team

The Clinical and Operations Team at TORL BioTherapeutics, LLC is responsible for overseeing the strategic planning, execution, and management of clinical trials for the company's novel antibody-based cancer therapeutics. This team ensures the trials are conducted in compliance with regulatory standards, coordinates with various stakeholders, and analyzes clinical data to advance the therapeutics through different phases of clinical development.

Clinical and Operations Team

Clinical Operations

TORL BioTherapeutics, LLC

Org chart

Teams

Leadership Team

Clinical and Operations Team

Clinical Operations

Offices

TORL BioTherapeutics, LLC

Org chart

Teams

Leadership Team

Clinical and Operations Team

Clinical Operations

Offices

Related companies